british farmers giant glaxo smith kline is dropping its bid to acquire fighters consumer healthcare busines. classes withdrawal follows that of record van keiser and johnson and johnson casting doubt on fighters ability to complete an auction at the u. s. drugmaker had hoped would bring in as much as twenty billion dollars. air france employees went on strike friday resulting in the cancellation of roughly a quarter of the airline's flights. pilot's cabin crew and ground staff joining the action to demand a six percent pay rise that following thursday's labor action is awesome three hundred thousand french workers walk out in protest of president emmanuel macron business friendly reforms. the world bank is placed one billion us dollars ivory coast for the development of its agriculture sector ivory coast is the world's number one cocoa producer and number two in cashew nuts but misses out on profits by exporting the commodities raw. ones are aimed at helping ivory coast realize more value added processing capacity. and ryanair is launching a service to ukraine irish low cost carriers as it

business anxiety as we head out of the european union, it was welcomed today by the boss of glaxo smith klineon sense. we certainly welcome this pragmatic approach to transition. it's absolutely critical to secure the supply of medicines and vaccines for the people here and in europe who need them. but we're also looking forward to more precision on the details of the end state of the relationship. and in that end state, if you like, what's the most important thing for gsk? that we get the security of supply to the people that need our medicines and our vaccines is absolutely critical, and the right kind of alignment with the regulators. harmonising rules on drugs between the uk and the eu is critical to a company that employs 16,000 people in the uk. gsk is already spending £50 million per year on its brexit planning. for business, this is a really important, really welcome moment in the whole brexit process. a little bit of breathing room to prepare for life outside of the eu. but as big businesses like banks and pharmaceutical companies are spending hundreds of millions of pounds on their

welcome back drug company glaxo smith kline or s.k. has paid thirteen billion dollars to know vargas to buy out a joint venture in consumer health products g s k's new c.e.o. hailed the deal saying it would boost earnings and reduce uncertainty on future capital management decisions that's because the original deal stipulated novartis could make g k g s k buyout their stake at any time now having bought out novartis g s k can move ahead novartis c.e.o. also said that he welcomed an opportunity to quote divest in non core assets at attractive price the venture still sell the venture sells health products under brands including excedrin theraflu and sense a done. and increasingly unpredictable work hours in service and retail industries have made making a living and having a life difficult for many workers but a new study finds that giving workers stable schedules with set hours is not just fair and humane it can be good for business and good for the company in this case the gap the clothier researchers looked at a dozen gap stores in sa

that's the glaxo smith kline story we would talking about earlier.t the end of last week, 1% down. the euro against the pound, the pound looking quite strongly against the euro at 87 cents. that was the business use. we will have more later. ben with some news coming through in the last few moments about more fallout from the collapse of bhs in 2016. details coming through from the insolvency service, which has been investigating the collapse of the chain. the insolvency service says it will ban dominic chappell and three other former directors of the stores from serving as a company director for the stores from serving as a company directorfor up to 15 the stores from serving as a company director for up to 15 years. dominic chappell, you may remember, is the man who bought the bhs chain from philip green forjust £1. it then collapsed mid—2016, ithink, with the loss of around 11,000 jobs, and then there were all the pension problems associated with that that you may well run as well. the insolvency service will and, nick chappel and three other dire

. >> i'm giving you several names, glaxo-smith kline today walking away from the pfizer deal the best gotten this morning besides the possibility i don't really think it's going to happen that president trump will veto this garbage. stuart: so you like glaxo? >> love it. they have 5.8% dividend and threatened if they went forward buying pfizer's unit, lever up their balance sheet to do it and walked away. stuart: glaxox pays me 5.8%, and that's a secure dividend no problem with that. well a secure dividend is a relative term but covered by free cash flow which is what we monitor and the answer is yes. stuart: give me another, a stock a big name. >> i think -- stuart: i want 6%. >> well then i'll give you an 8% name plaquestone, bx. blackstone again covering their dividend from free cash flow the best run asset manager i've ever observed in my career both alternative and real estate credit exposure the absolute cream of the crop, paying an 8% dividend. stuart: see that's what i want, with cash flow to back it up love it carve id you're all right thanks for joining us on a very big day.